SYK inhibitor entospletinib prevents ocular and skin GVHD in mice-Reference-Cited by-同舟云学术

SYK inhibitor entospletinib prevents ocular and skin GVHD in mice

Published:2018-10-04 Issue:19 Volume:3 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Poe Jonathan C.,Jia Wei,Di Paolo Julie A.,Reyes Nancy J.,Kim Ji Yun,Su Hsuan,Sundy John S.,Cardones Adela R.,Perez Victor L.,Chen Benny J.,Chao Nelson J.,Cardona Diana M.,Saban Daniel R.,Sarantopoulos Stefanie

Funder

National Institutes of Health

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/122430/files/pdf

Reference69 articles.

1. Acute Graft-versus-Host Disease — Biologic Process, Prevention, and Therapy

2. Pathogenesis of acute graft-versus-host disease: from intestinal microbiota alterations to donor T cell activation

3. Mechanistic approaches for the prevention and treatment of chronic GVHD

4. Classification systems for chronic graft-versus-host disease

5. Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Approaches for the Prevention and Treatment of Acute and Chronic GVHD;Cells;2024-09-11

2. Long-Term Clinical Outcomes and B Cell Immune Reconstitution Following Allo-HCT With Prophylactic, Post-Transplant Rituximab;Transplantation and Cellular Therapy;2024-05

3. The ABCB1 and ABCG2 efflux transporters limit brain disposition of the SYK inhibitors entospletinib and lanraplenib;Toxicology and Applied Pharmacology;2024-04

4. Cellular senescence promotes meibomian gland dysfunction in a chronic graft-versus-host disease mouse model;The Ocular Surface;2024-04

5. Lessons Learned From Ocular Graft versus Host Disease: An Ocular Surface Inflammatory Disease of Known Time of Onset;Eye & Contact Lens: Science & Clinical Practice;2024-03-22